Changes to CredibleMeds Lists - Smartphone Apps
March 14, 2017 at 5:31 PM
The safe use of the CredibleMeds® lists of medications requires that the user have the most up-to-date lists of drugs. Therefore, we wnat to inform you of the following changes to the QTdrugs.org lists: (Pilsicainide, prothipendyl and terodiline were added on 2/11/17)
1. Addition of Ketanserin, prothipendyl and pilsicainide (all on markets outside the USA) to the Possible Risk (PR) List.
2. Move Solifenacin from the Possible Risk list to the Conditional Risk (CR) List.
3. Addition of terodiline (Micturin and Mictrol) to the Known Risk (KR) List. Note that the brand Mictrol may contain a different drug (bethanechol) in some countries. Terodiline has been removed from the US and many other markets worldwide.
Also, we remind you of the availability of the newly released, free CredibleMeds Mobile Apps !
You can access the iPhone application by going to the iPhone, Google Play or Windows Mobile App stores.
The Apps are synced to the CredibleMeds drugs lists and are therefore always an up-to-date resource for you to search for drugs of interest.
We hope you will find the Apps to be of value and we seek your feedback for ways they might be improved to better serve your needs.
We wish to recognize the support of the FDA's Safe Use Initiative, the Bert W. Martin Foundation, numerous donors and the technical expertise of Keith Symmonds, a talented programmer with Congenital Long QT Syndrome, that made these Apps possible.
Thank you for your support of CredibleMeds.org.
Please add a comment
You must be logged in to leave a reply. Login »